Emtansine is a chemotherapy drug ... Targeting cancer cells can help prevent some side effects that traditional chemotherapy can cause. Can Kadcyla cause long-term side effects?

Side effects, Beck explained, can be gastrointestinal or can include ... Compared to another antibody-drug conjugate, Kadcyla (ado-trastuzumab emtansine), Enhertu has been shown, Beck said, to result ...

If you have certain side effects, you may have to have to change ... Enhertu with another ADC that targets HER2, ado-trastuzumab emtansine (Kadcyla). Enhertu worked better in treating breast ...

Trastuzumab emtansine (T–DM1) is a novel ADC that combines the humanized ... The anticipated selective activity and reduction in side effects were thus noted. Randomized multicenter phase III trials ...

FDA Approves Genentech's Kadcyla (Ado-Trastuzumab Emtansine), the First Antibody ... There are possible serious side effects of Kadcyla. Patients must contact their doctor right away if they ...

The antibody-drug conjugate trastuzumab emtansine (trade name ... "health-related quality of life" and "serious or severe side effects" together provide an indication of a major added benefit.

SAN ANTONIO – A combination of two HER2-targeted drugs, tucatinib (Tukysa) and trastuzumab emtansine (Kadcyla ... rate of certain treatment-related side effects, especially those related ...